These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 37832523)
1. ADP-ribosylation from molecular mechanisms to therapeutic implications. Suskiewicz MJ; Prokhorova E; Rack JGM; Ahel I Cell; 2023 Oct; 186(21):4475-4495. PubMed ID: 37832523 [TBL] [Abstract][Full Text] [Related]
2. General ADP-Ribosylation Mechanism Based on the Structure of ADP-Ribosyltransferase-Substrate Complexes. Tsuge H; Habuka N; Yoshida T Toxins (Basel); 2024 Jul; 16(7):. PubMed ID: 39057953 [TBL] [Abstract][Full Text] [Related]
3. ADP-ribosylation: An emerging direction for disease treatment. Liu YT; Che Y; Qiu HL; Xia HX; Feng YZ; Deng JY; Yuan Y; Tang QZ Ageing Res Rev; 2024 Feb; 94():102176. PubMed ID: 38141734 [TBL] [Abstract][Full Text] [Related]
4. ADP-ribosylation of DNA and RNA. Groslambert J; Prokhorova E; Ahel I DNA Repair (Amst); 2021 Sep; 105():103144. PubMed ID: 34116477 [TBL] [Abstract][Full Text] [Related]
5. ADP-ribosylation signalling and human disease. Palazzo L; Mikolčević P; Mikoč A; Ahel I Open Biol; 2019 Apr; 9(4):190041. PubMed ID: 30991935 [TBL] [Abstract][Full Text] [Related]
6. Insights into the biogenesis, function, and regulation of ADP-ribosylation. Cohen MS; Chang P Nat Chem Biol; 2018 Feb; 14(3):236-243. PubMed ID: 29443986 [TBL] [Abstract][Full Text] [Related]
7. ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease. Lüscher B; Bütepage M; Eckei L; Krieg S; Verheugd P; Shilton BH Chem Rev; 2018 Feb; 118(3):1092-1136. PubMed ID: 29172462 [TBL] [Abstract][Full Text] [Related]
8. ENPP1 processes protein ADP-ribosylation in vitro. Palazzo L; Daniels CM; Nettleship JE; Rahman N; McPherson RL; Ong SE; Kato K; Nureki O; Leung AK; Ahel I FEBS J; 2016 Sep; 283(18):3371-88. PubMed ID: 27406238 [TBL] [Abstract][Full Text] [Related]
9. ADP-ribosylation: new facets of an ancient modification. Palazzo L; Mikoč A; Ahel I FEBS J; 2017 Sep; 284(18):2932-2946. PubMed ID: 28383827 [TBL] [Abstract][Full Text] [Related]
10. ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives. Manco G; Lacerra G; Porzio E; Catara G Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327636 [TBL] [Abstract][Full Text] [Related]
11. Specificity of reversible ADP-ribosylation and regulation of cellular processes. Crawford K; Bonfiglio JJ; Mikoč A; Matic I; Ahel I Crit Rev Biochem Mol Biol; 2018 Feb; 53(1):64-82. PubMed ID: 29098880 [TBL] [Abstract][Full Text] [Related]
12. The expanding universe of PARP1-mediated molecular and therapeutic mechanisms. Huang D; Kraus WL Mol Cell; 2022 Jun; 82(12):2315-2334. PubMed ID: 35271815 [TBL] [Abstract][Full Text] [Related]
13. MARTs and MARylation in the Cytosol: Biological Functions, Mechanisms of Action, and Therapeutic Potential. Challa S; Stokes MS; Kraus WL Cells; 2021 Feb; 10(2):. PubMed ID: 33546365 [TBL] [Abstract][Full Text] [Related]
14. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro. Lin KY; Huang D; Kraus WL Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863 [TBL] [Abstract][Full Text] [Related]
15. Beyond protein modification: the rise of non-canonical ADP-ribosylation. Schuller M; Ahel I Biochem J; 2022 Feb; 479(4):463-477. PubMed ID: 35175282 [TBL] [Abstract][Full Text] [Related]